Understanding the fundamentals of basic biology can result in new cancer treatments.
A reported study has shown that RNA polymerases, or RNA polymers, have the capabilities of controlling rampant cell growth that’s otherwise known to cause cancer in the body.
Polymerase I and Polymerase II
RNA polymers are essentially enzymes that create RNA based on the genetic code that is found in DNA molecules. The two polyermases, known as polymerase I and polymerase II have similar cellular roles that contribute to the cause with each other instead of interfering with one another’s function. This is a surprising discovery as it leads to a potential exploitation to develop a line of drugs that may control rapid cell growth.
The application of these polymerases within medicine can help control unregulated growth and provide more insight into how the RNA-producing process affect cell growth associated with cancer.
Consider polymerases as chain-building machines. Every chain link that’s created signals a new phase in the transcription process. However, each link requires a series of chemical reactions to occur, which affects the overall chain growth rate. With the application of polymerase I and polymerase II, they can intervene within the altered “chain links” to provide more stability regarding the growth factor.
With a closer look into RNA polymerases and the process of RNA synthesis, there could potentially be more in-depth information in the works for cancer chemotherapy. With a long-term therapeutic agent still in development, there’s still a long road ahead for providing treatment, but better understanding fundamental biological cellular functions is a good first step.
The Midland Certified Reagent Company offers oligos, including dual-labeled probes, for DNA synthesis, RNA Synthesis, and more.